Thromb Haemost 2017 08 11;117(8):1465-1470. Epub 2017 May 11.
Karin van Galen, MD, University Medical Center Utrecht, Van Creveldkliniek, Heidelberglaan 100, Room C01.425, PO box 85500, 3508 GA Utrecht, The Netherlands, Tel.: +31 8 875 584 50, Fax: +31 88 75 554 38, E-mail:
Assessment of clinical outcome after joint bleeding is essential to identify joint damage and optimise treatment, to prevent disability. However, disease-specific tools to assess the musculoskeletal status in patients with von Willebrand disease (VWD) are lacking. We aimed to determine validity and reliability of the Haemophilia Joint Health Score (HJHS) and Haemophilia Activities List (HAL) in patients with Von Willebrand disease (VWD). Read More